NCT03682354 is a NA clinical trial of Intercostal Nerve Block with PCIA in Lung Diseases, sponsored by Peking University Third Hospital.

Who is sponsoring NCT03682354?

NCT03682354 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT03682354?

Interventions in NCT03682354: Intercostal Nerve Block with PCIA, Erector Spinae Plane Block (ESPB).

What condition does NCT03682354 study?

NCT03682354 studies Lung Diseases.

Is NCT03682354 still recruiting?

NCT03682354 is currently completed. Last updated 27 March 2019.

Last reviewed 2019-03-27 · How we verify

NCT03682354

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery

Completed NA Last updated 27 March 2019

What this trial tests

NA trial testing Intercostal Nerve Block with PCIA in Lung Diseases in 70 participants. Completed in 15 March 2019.

Timeline

27 September 2018

Primary endpoint
15 March 2019

15 March 2019

Quick facts

Lead sponsor	Peking University Third Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	70
Start date	27 September 2018
Primary completion	15 March 2019
Estimated completion	15 March 2019
Sites	1 location across China

Drugs / interventions tested

Intercostal Nerve Block with PCIA — full drug profile →
Erector Spinae Plane Block (ESPB) — full drug profile →

Conditions studied

Lung Diseases — all drugs for Lung Diseases →

Sponsor

Peking University Third Hospital

Who can join

Adults 18 to 70, any sex, with Lung Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized prospective trial to test the non-inferiority of erector spinae plane block (ESPB) in comparison with intercostal nerve block combined with patient-controlled intravenous analgesia in Thoracoscopic lung surgery

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Programmed Intermittent Bolus for Erector Spinae Plane Block Versus Intercostal Nerve Block With Patient-controlled Intravenous Analgesia in Video-assisted Thoracoscopic Surgery: A Randomized Controlled Noninferiority Trial.
Wang T, Wang X, Yu Z, Li M. · · 2024 · cited 9× · PMID 37975501 · DOI 10.1097/ajp.0000000000001174

Verify or expand the search:

Other recruiting trials for Lung Diseases

Currently open trials in the same condition.

NCT07356076 — The Use of Electrical Impedance Tomography (EIT) in Pulmonary Diseases · recruiting
NCT07243964 — Multi-Omics-Based Prediction of Allograft Dysfunction After Lung Transplantation · recruiting
NCT07270744 — Data Collection Using Eko Devices in a Clinical Setting · recruiting
NCT07227376 — Data Collection Using Eko Digital Devices in a Clinical Setting · recruiting
NCT06917573 — PALACE: Cemiplimab Trial According to ctDNA Levels · Phase 2 · recruiting

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03682354 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 27 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03682354.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing